The invention pertains to medicine and concerns the application of the hexapeptide tyrosyl-D-alanyl-glycyl-phenylalanyl-leucyl-arginine in the treatment of skin wounds or burns as a medicinal product for topical use.Agent for the treatment of skin wounds of burns in the form of a dosage form for topical use containing the hexapeptide tyrosyl-D-alanyl-glycyl-phenylalanyl-leucyl-arginine at 0.02 - 0.5 weight % as the active ingredient, with a pharmaceutically acceptable excipient / pharmaceutically acceptable excipients making up the rest.The agent contributes to rapid healing of skin wounds and burns by stimulating tissue regeneration processes in the affected area and reducing the severity of productive inflammation. 2 dependent claims, 5 examples, 4 tables and 4 figures.
